USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 11,835 shares of the company’s stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $66.07, for a total value of $781,938.45. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

USANA Health Sciences, Inc. (NYSE:USNA) opened at $66.00 on Friday. The firm has a market capitalization of $1,583.54, a PE ratio of 17.46 and a beta of 1.07. USANA Health Sciences, Inc. has a 52-week low of $52.55 and a 52-week high of $71.00.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, October 24th. The company reported $1.02 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.11. The company had revenue of $261.77 million during the quarter, compared to analysts’ expectations of $259.52 million. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. USANA Health Sciences’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.40 earnings per share. equities research analysts predict that USANA Health Sciences, Inc. will post 3.7 EPS for the current fiscal year.

USANA Health Sciences declared that its Board of Directors has approved a stock repurchase plan on Tuesday, July 25th that authorizes the company to buyback $64.60 million in shares. This buyback authorization authorizes the company to purchase up to 46% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its stock is undervalued.

TRADEMARK VIOLATION NOTICE: This article was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The original version of this article can be viewed at https://www.watchlistnews.com/insider-selling-usana-health-sciences-inc-usna-director-sells-781938-45-in-stock/1713560.html.

A number of hedge funds and other institutional investors have recently modified their holdings of USNA. Renaissance Technologies LLC boosted its position in USANA Health Sciences by 10.6% during the second quarter. Renaissance Technologies LLC now owns 1,948,266 shares of the company’s stock valued at $124,884,000 after purchasing an additional 186,600 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its position in USANA Health Sciences by 711.5% during the second quarter. Arrowstreet Capital Limited Partnership now owns 91,409 shares of the company’s stock valued at $5,859,000 after purchasing an additional 80,145 shares during the last quarter. FMR LLC boosted its position in USANA Health Sciences by 3.9% during the second quarter. FMR LLC now owns 1,598,143 shares of the company’s stock valued at $102,441,000 after purchasing an additional 60,033 shares during the last quarter. Old Mutual Global Investors UK Ltd. boosted its position in USANA Health Sciences by 29.7% during the second quarter. Old Mutual Global Investors UK Ltd. now owns 239,680 shares of the company’s stock valued at $15,363,000 after purchasing an additional 54,831 shares during the last quarter. Finally, Schroder Investment Management Group boosted its position in USANA Health Sciences by 9.0% during the second quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock valued at $36,734,000 after purchasing an additional 47,448 shares during the last quarter. 44.54% of the stock is owned by hedge funds and other institutional investors.

Several research firms have recently weighed in on USNA. BidaskClub cut USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research report on Monday, July 31st. Pivotal Research upped their price objective on USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, October 25th.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.